Benfotiamine
Product Description
AMI Life Sciences
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Primary activities
AMI Life Sciences
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Primary activities
More Products from AMI Life Sciences (83)
-
Product Fimasartan
Anti-Hypertensive -
Product Eslicarbazepine Acetate
Anti-Epileptic -
Product Doxofylline
Anti-Asthmatic -
Product Desvenlafaxine Succinate
Anti-Depressant -
Product Choline Fenofibrate
Lipid Lowering -
Product Benzonatate
Anti-Tussive -
Product Acebrophylline
Anti-Asthmatic -
Product Acebrophylline
Ami LifeSciences provides a wide range of respiratory tract drugs which includes acebrophylline. It belongs to active pharmaceutical ingredients category. It is used for the treatment of chronic obstructive pulmonary disease (COPD)/ mucolytic-bronchodilator. Contact us for more information. -
Product Benzonatate
Ami LifeSciences provides a wide range of respiratory tract drugs which includes Benzonatate. It belongs to active pharmaceutical ingredients category. It is used for the treatment of non-narcotic anti-tussive. Contact us for more information. -
Product Choline Fenofibrate
Ami LifeSciences provides a wide range of cardiovascular diseases drugs which includes Choline Fenofibrate. It belongs to active pharmaceutical ingredients category. It is used for the treatment of lipid lowering agent. Contact us for more information. -
Product Dapoxetine HCL
Ami LifeSciences provides a wide range of erectile dysfunction drugs which includes Dapoxetine HCL. It belongs to active pharmaceutical ingredients category. It is used for the treatment of premature ejaculation. Contact us for more information. -
Product Desvenlafaxine Succinate #
Ami LifeSciences provides a wide range of central nervous system drugs which includes Desvenlafaxine Succinate #. It belongs to active pharmaceutical ingredients category. It is used as an anti-depressants medicine. Contact us for more information.
